Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Uman Diagnostics and Bio-Techne announced a strategic License and Supply Agreement for the antibodies used in the quantification of Nf-L on the ProteinSimple™-branded Ella™ immunoassay platform.
read more
Tuesday, October 20, 2020
Precigen announced the FDA clearance and successful technology transfer for its UltraPorator system, a proprietary software solution for the scale-up of rapid and cost-effective manufacturing of UltraCAR-T therapies.
read more
Friday, December 18, 2020
Ultragenyx Pharmaceutical and Mereo BioPharma Group announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
read more
UL has launched an outreach program for governments and vaccine manufacturers to promote the safe and effective production, distribution, and administration of COVID-19 vaccines.
read more
Thursday, January 18, 2024
The Cell and Gene Therapy Catapult (CGT Catapult), an independent organization dedicated to advancing cell and gene therapies, has unveiled the UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database.
read more
Friday, November 09, 2018
The UK BioIndustry Association has been granted permission by the UK Supreme Court to intervene in a case that could have far-reaching impacts on the life sciences sector.
read more
Monday, November 28, 2022
BioPharma Dynamics is expanding their portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors.
read more
UDG Healthcare announced the acquisition of Create NYC and SmartAnalyst for a combined consideration of up to $82.4 million.
read more
Outcome Capital announced UCB Pharma has acquired privately held Beryllium Discovery.
read more
The March of 2013 grand opening of the Boca Raton Clinical Research (BRCR) facility in Lima, Peru was a significant event some 3,700 miles away.
read more
The University of California, Irvine (UC Irvine) and GlyTR Therapeutics are advancing a preclinical CAR-T program targeting solid tumors, supported by adeno-associated virus (AAV) manufacturing from CDMO ProBio.
read more
Thursday, January 30, 2020
Ubiquigent announced the launch of an exciting new service as part of its Drug Discovery Screening Platform – DUBprofiler-Cell™.
read more
Tuesday, October 26, 2021
Ubiquigent Limited (Ubiquigent) today announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide Bristol Myers Squibb with increased access to its ...
read more
Ubiquigent announced the continuation of a collaboration with Bristol Myers Squibb.
read more
Croda International Plc has entered into a cooperative agreement with the United States government in which the government will provide up to $75 million to expand the company’s U.S. manufacturing capacity of ingredients for lipid systems used in ...
read more